News & Alerts
-
Aug- 2023 -2 August
How Lancaster County in Pennsylvania Plans To Spend Opioid Settlement Funds
After thorough deliberations, Lancaster County officials have reached a consensus on how to allocate opioid settlement money, identifying their drug…
Read More » -
2 August
Unraveling the Untold Story of Henrietta Lacks and Medical Marvels
Henrietta Lacks was an African-American woman from Virginia, USA, who sought medical treatment for cervical cancer at Johns Hopkins Hospital…
Read More » -
1 August
Restructuring: 5,000 CVS Health Employees To Lose Their Jobs
CVS Health has confirmed the elimination of several “non-customer facing positions” across the company as part of an enterprise initiative…
Read More » -
1 August
How Internationally-Trained Doctors and Pharmacist Can Immigrate and Work In The US & Canada
The United States and Canada are grappling with shortages of doctors and pharmacists in certain regions and specialties. These shortages…
Read More » -
1 August
A Review Of Over 200 Studies Reveal The Gold Standard For Acne Treatment
Acne is a highly prevalent skin condition that affects a large portion of the population, particularly during adolescence and early…
Read More » -
1 August
How Abdominal Fat Affects Crohn’s and Colitis Medications – Study
A new research published on July 25 in the Journal Gastroenterology has revealed that certain medications might not effectively treat…
Read More » -
1 August
Lupin Pharmaceuticals Recalls 2 Lots of Tydemy Over OOS Results
According to a press release by the FDA, Lupin Pharmaceuticals Inc. (Lupin) is voluntarily recalling two (2) lots of Tydemy (Drospirenone, Ethinyl…
Read More » -
Jul- 2023 -31 July
FDA Rejects Citius Bid to Replace Ontak With Lymphir
Recently, Citius Pharmaceuticals faced a significant setback when the U.S. Food and Drug Administration (FDA) rejected their application for Lymphir…
Read More » -
31 July
Takeda Faces Setback as Phase 3 Trial for Promising Lung Cancer Drug Exkivity Fails
In a major blow to Takeda Pharmaceutical Company, the highly anticipated targeted non-small cell lung drug Exkivity has suffered a…
Read More » -
31 July
Why Dr. Irene Kimura’s License Was Revoked Permanently
A Washington physician, Dr. Irene Kimura, has had her medical license permanently revoked by the Washington Department of Health after…
Read More »